TARGET THERAPEUTICS' GDC COIL CLEARANCE PUTS SPRING IN STOCK'S SEPTEMBER GAINS AS ISSUE CLIMBS 21-1/4 TO 70; O-T-C MONTHLY STOCK INDEX ADVANCES 6.5%
This article was originally published in The Gray Sheet
Executive Summary
Investors rewarded Target Therapeutics' three-year effort to secure market clearance of the Guglielmi Detachable Coil with a 6-1/4 point stock gain on Sept. 14, the day the company announced clearance of the device.